Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REPOTRECTINIB vs REVATIO: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REPOTRECTINIB vs REVATIO: Safety Overview

Metric REPOTRECTINIB REVATIO
Total FAERS Reports 187 434
Deaths Reported 27 199
Death Rate 14.4% 45.9%
Hospitalizations 48 110
Average Patient Age 60.8 yrs 65.1 yrs
% Female Patients 61.1% N/A
FDA Approval Date Jun 11, 2024 N/A
Manufacturer E.R. Squibb & Sons, L.L.C. N/A
Route ORAL N/A
Marketing Status Prescription N/A